A Maynard, G Hardman, A Whelan. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisEnglandHumansIllicit DrugsSubstance-Related Disorders/economics
Substances: See more » Illicit Drugs
Year: 1987 PMID: 3111511 DOI: 10.1111/j.1360-0443.1987.tb01533.x
Source DB: PubMed Journal: Br J Addict ISSN: 0952-0481